collecte section Bourgogne

https://www.helloasso.com/associations/association-france-lyme/collectes/section-bourgogne

A Window Into Lyme Disease Using Private Claims Data

As we end the year, here is a 2017 review of private claims data which tracks the rising incidence and effects of Lyme disease. This includes symptoms reported to insurers (increased rates of fatigue, and pain, with higher fibromyalgia diagnoses), rising rates of the incidence of LD in rural and urban communities (including the southern parts of the US!), and autoimmune manifestations. These figures do not account for those individuals diagnosed with Lyme "mimics" including CFS/ME, other autoimmune illness such as seronegative RA or MS, or early dementia and neuropsychiatric illness that are due to Lyme, associated co-infections and overlapping inflammatory conditions on the 16 point MSIDS map. The numbers are therefore probably much higher. Dr Holly Ahern did a study years ago that showed that although 2% of respondents reported being diagnosed with LD according to CDC criteria for “probable” Lyme disease (which was significantly higher than the number of reported cases i.e., 0.3% of the US population in 2012), 16% percent of undiagnosed survey respondents reported subjective signs and symptoms consistent with “late-stage” Lyme disease (Ahern, H. Comparison of Lyme Disease Prevalence and Disease Reporting in an Endemic Area, Journal of Microbiology Research, Vol. 3 No. 6, 2013, pp. 261-265. doi: 10.5923/j.microbiology.20130306.11).
The full range of physical, mental, emotional and financial burdens is also not reflected in this report, but it does give a sense of the spreading problem and urgency to address tick-borne diseases in the US.
 

 
 
Claims data are used to track rising incidence of Lyme disease and its relationship to autoimmune disease.
ajmc.com